Skip to main content Skip to main navigation menu Skip to site footer
Subscription Contact the editors
  • en
  • ru
Problems of Social Hygiene, Public Health and History of Medicine
ISSN 0869-866X (Print)
ISSN 2412-2106 (Online)
  • Current
  • Archive
  • About
    • About the Journal
    • Author Guidelines
    • Editorial Masthead
    • Privacy Statement
  • Editorial Board
  • Contact
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • THE TEMPTATION OF RUSSIAN PHARMA. REPORT II: THE IMPLEMENTATION OF THE PROGRAM OF ADDITIONAL MEDICINAL SUPPORT

    Ignatiev V.G.
    658-664
    2023-12-15
    Abstract

    The second article in series of publications considering history of implementation of the government program of additional medication support from point of view of conditions of development of pharmaceutical market in Russia. The study is carried out on the basis both of interviews of participants of pharmaceutical market and state administrators and publications in specialized editions in 2020—2022. The first experience of close interaction of pharmaceutical business with government in implementation of social policy is analyzed. The focus is made on failures in practical implementation of the program of additional medication support, in which course alliance of government and pharmaceutical business cracked.

  • The Renaissance of Russian pharmaceutical market (2000-2004). Report I. The field players

    Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
    1358-1366
    2022-12-15
    Abstract
    The article (third one out of author's cycle of historical studies of medicinal provision and pharmaceutical business) considers period of economic renaissance of Russian pharmaceutical market during the first five years of Third Millennium. The market conditions are analyzed according data of Russian analytical agencies, materials of medical periodicals and memories of participants. The article is composed of three reports. The first report demonstrates changes in composition of essential players on market field that occurred after 1998 default.
  • The development of regulation of pharmaceuticals turn-over in EU and the USA in 1992–2020. Report 2. Development of normative legal base of pharmaceuticals turn-over in EU in 1992–2001

    Volskaya E.A.
    2025-04-25
    Abstract

    The article continues to consider problem of regulation of pharmaceuticals turn-over in the EU and the USA in 1992–2020. The history of development of European pharmaceutical legislation in 1992–2001 is considered. This stage is characterized by passing Directives (laws of indirect action) that were obligatory for implementation through their inclusion into national normative legal bases. In 2001 the passed laws were compiled into EU Pharmaceutical Code (Directive 2001/83) that regulates main sections of pharmaceuticals turn-over from their production to pharmaceutical control. The adoption of Code laid the foundation for EU legislation in the field of medications.

  • THE MEDICAL REPRESENTATIVES, OR DEBATES OF 2010S ABOUT PROMOTION OF MEDICATIONS

    Vishlenkova E.A., Zatravkin S.N.
    651-657
    2023-12-15
    Abstract
    The article considers the issue of the restrictions imposed by the government in the 2010s into process of introducing and promoting medications at the market by means of medical representatives. The government decided to formalize relationships of pharmaceutical manufacturers with consumers of medications. On the one hand, such a trend was occurring all over the world and was stimulated by social attacks at Big Pharma under slogan “the conflict of interests”. On the other hand, at the Russian pharmaceutical market, the restrictions of direct contacts of pharmaceutical manufacturers with physicians and and pharmaceutists were supported above all by national manufacturers of medicines. In the course of competition, vast army of Russian medical representatives was stigmatized that made many medics either to leave pharmaceutical market or to limit themselves to formal duties.
  • The default of 1998 and pharmaceutical market. Report I. The chronicle of disaster

    Zatravkin S.N., Ignatiev V.G., Vishlenkova E.A.
    683-691
    2022-12-15
    Abstract
    The researchers, in series of articles, analyze significance of the default of 1998 for both pharmaceutical industry and participants of pharmaceutical market. The Report I presents results of investigation of corresponding economic and social aspects of issue. The article presents contradictions in tax and financial policies of then ruling authorities; regulatory drawbacks created by inefficient awareness of economic situation and social specificity of pharmaceutics; means for pharmaceutical companies to survive in these conditions.
  • The characteristics of regulation of pharmaceutical market of the Eurasian Economical Union

    Marseva T.G., Voblaia I.N., Seifieva E.N.
    841-846
    2019-12-15
    Abstract
    The article considers one of the most pressing problems - the turnover of medicines within the common pharmaceutical market of the Eurasian Economic Union. The drug market is an essential aspect of social policy, reflecting general welfare of citizens and the level of the country's national security. The object of the study is the importation of medicines into the customs territory of the Eurasian Economic Union (EAEU), and the subject is the social and legal relationship when importing medicines, problems and ways to improve the procedure of importing medicines into the territory of the EAEU. At the present stage of development of civil society, a number of countries of the Commonwealth of Independent States are closely cooperating in improving the quality and level of living of population, complying with basic social guarantees, including providing affordable and high-quality medical and drug assistance. The indicator of country's development in the field of medicine is the ability to develop and to test drugs, because these processes are considered as the most complex, expensive and risky, as well as to control the circulation of drugs created by “pseudo-companies” producing counterfeits for well-known pharmaceutical companies. The problem of falsification leads to an outflow of capital outside the EEU, threat to health and lives of consumers, violation of the right holders’ rights, discredit foundations of the state structure of the EEU member countries that are not able to provide guarantees for the safety of drug consumption. The creation of common pharmaceutical market within the Eurasian Economic Union will in the future not only provide control of circulation of medicines on the territory of the EAEU, but also contribute to the development of national pharmaceutical industry by expanding distribution channels and expanding range of drugs produced by foreign manufacturers established on the territory of the EAEU.
  • THE TEMPTATION OF RUSSIAN PHARMA. REPORT I: THE DESIGN OF PROGRAM OF ADDITIONAL MEDICINAL SUPPORT OF PARTICULAR CATEGORIES OF CITIZEN

    Ignatiev V.G.
    465-472
    2023-12-15
    Abstract
    The series of articles is devoted to examination of history of implementing the Government program of supplementary medicinal support from the point of view of conditions of development of pharmaceutical market in Russia. The research is based both on the interviews with pharmaceutical market participants and government administrators organized in 2020–2022, and research publications in specialized editions. The first experience of close interaction between the pharmaceutical business and the Government in implementing social policy is analyzed. The first report reveals concept of developing given program, demonstrates its commercial and social attractiveness.
  • The Russian pharmaceutical industry in 1990s. Report III. Insider vision

    Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
    503-507
    2022-12-15
    Abstract
    The third report, which is a continuation of article on the Russian pharmaceutical branch in the 1990s, analyses corresponding conceptions of internal observers (participators of production and distribution of medications), including their assessments of normality of emerging market. The conclusion is made that the Russian pharmaceutical market grew from chaos that resulted from wreckage of the Soviet medication supply system in 1994-1998. The general dominance of generics over patented medications, distributors over manufacturers, weak interest of state authorities to long-term cooperation with pharmaceutics for the sake of development of own national production, low legal culture were generic characteristics of its infrastructure.
  • The long 1992 year in medicinal (non-)security of Russia. Report I. Market trial

    Ignatiev V.G., Zatravkin S.N., Vishlenkova E.A.
    2025-04-21
    Abstract

    The year 1992 is an important landmark in the history of Russian pharmaceutical market. It began not in January, but in December 1991, when orders of the President and the Government to open free market of medications were promulgated. The Yeltsin advisers conceived that market economy was infallible means to combat medication shortages, corruption and bureaucratic monopoly. However, panacea did not work. Moreover, it gave rise to completely new problems. The human and state security implies protection from threats of dependence. The unprepared dive into market plunged Russians and the country into deep dependence on imported medications and foreign pharmaceutical companies.
    The proposed study proceeds our publications in this journal and in journal “Pharmacia” in 2022. At that time, analysis of medication “famine” was implemented on basis of published sources and relied on journalistic evidences. The current study was carried out on the basis of archive documents of the Ministry of Health of the Russian Federation and authors interviews of representatives of the regulator. The first report reveals administrative mechanism that engendered crisis of medication supply in the first post-Soviet year of our country.

  • THE PROBLEM OF FORMATION OF NEW RISKS OF MEDICINAL RESISTANCE OF PATIENTS WITH TUBERCULOSIS IN CONDITION OF ACTIVE USE OF ANTIBIOTICS BY POPULATION UNDER COVID-19

    Bulycheva E.V., Bulychev V.V., Pashkova N.A.
    157-163
    2023-12-15
    Abstract
    In pandemic conditions, situation of active and uncontrolled use by population of antimicrobial preparations treating COVID-19 occurs. So, new risks of development of medication resistance among patients with various infectious diseases, tuberculosis included, appear. The purpose of the study is to characterize prevalence of antimicrobial preparations use by population in relationship with development of medication resistance in patients with tuberculosis during COVID-19 pandemic. Material and methods. The analysis of sales of antimicrobial medicines was implemented on the basis of published official data from the joint-stock company DSM Group presenting monthly audit of the Russian pharmaceutical market. The determination of primary antibiotic resistance was carried out in 2018–2020 on 3312 patients with tuberculosis. The modified method of proportions on liquid nutrient medium in system with automated accounting of microorganisms growth, the method of absolute concentrations and the method of polymerase chain reaction with real-time detection were applied. The results of the study. It was established that the most demanding antimicrobial medications among population were ceftriaxone, azithromycin, levofloxacin, moxifloxacin, azithromycin. At the same time, the maximum increase in sales in 2020 up to 150% as compared with of 2019 was determined in medications derived from quinolone moxifloxacin, levofloxacin, which began to be used in treatment of coronavirus infection. At the same time, these medications are traditionally used in tuberculosis treatment. But in 2020, alarming trend was established that limits treatment of tuberculosis patients. The primary resistance of mycobacteria was also established in newly diagnosed tuberculosis patients, also for the same antimicrobial medications of quinolone derivatives, and increasing in proportion of patients with primary medication resistance to levofloxacin, moxifloxacin in 2020 as compared to 2018 was 189–480%. At the same time, increasing of resistance to other antibiotics made up to 60.8% on average. Conclusion. The study results imply alarming scenario of medication resistance shifts towards very virulent and highly medication‐resistant genotypes. This trend can result in conditions of successful transmission of deadly medication-resistant mutants that can seriously undermine effectiveness of implemented programs of struggle with tuberculosis worldwide.
  • The Russian pharmaceutical branch in 1990s. Report II. The optics of external observers

    Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
    322-328
    2022-12-15
    Abstract
    The article proceeds to explore history of the pharmaceutical branch in the 1990s. The changes in system of medicinal supply in Russia are demonstrated through infrastructural transformations and their assessment by political figures and regulators of pharmaceutical market.
  • THE TEMPTATION OF RUSSIAN PHARMA. REPORT III: NEW EXPERIENCES AND PARTNERS

    Ignatiev V.G.
    1041-1047
    2023-12-15
    Abstract
    The series of articles considers history of implementation of government program of supplementary medications supply from point of view of conditions of development of pharmaceutical market conditions in Russia. The study was implemented on basis of interviews of pharmaceutical market participants and government administrators in 2020–2022 and specialized publications. The first experience of right interaction between pharmaceutical business and government in the implementation of social policy is analyzed. The report III is devoted to analysis of experiences acquired by pharma from participation in political agenda and interaction with government on state sector of economics.
  • THE RENAISSANCE OF RUSSIAN PHARMACEUTICAL MARKET (2000–2004). REPORT III. THE INTERESTS OF CONSUMERS

    Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
    290-296
    2023-12-15
    Abstract
    The article (the third one in author’s series of historical studies of drug supply and pharmaceutical business) examines the period of economic renaissance of the Russian pharmaceutical market in the first years of the third millennium. The analysis of state of the market based on data from Russian analytical agencies, medical periodicals and recollections of participants is presented. The article consists of three reports. The first one considered “field players” of the pharmaceutical market (owners of different types of pharmaceutical business). The second one dealt with all the personnel serving the market game (Russian employees of pharmaceutical companies) and their reflection of the new, post-Soviet experience of living in private business. The third report covers issue of “spectators and judges” i.e. consumers in broad sense of word: from state to buyers of pharmacy medications. The conflicting interests of state structures and officials who played double role (bulk buyers and regulators) as well as needs and problems of retail consumers of pharmaceutical production are demonstrated.
  • The Russian pharmaceutical market: the main trends of development and pricing in modern conditions

    Botnaryuk M.V., Timchenko T.N.
    198-206
    2022-12-15
    Abstract
    The National Russian pharmaceutical market is exposed to strong impact of external environment therefore its transformation is inevitable. Yet, development of market is strategically important for Russia that requires permanent monitoring and timely development of normative documents and target programs focused on supporting of population social guarantees. The global digitization of all industries, including pharmaceutical revealed urgent necessity in shifting accents to area of internet-marketing and internet-trade while elaborating rules of realization of sales of medications. The economical and political actualities of further advancing of concept of import substitution, development of mechanisms of state support of all agents of pharmaceutic market and also strategy of pricing considering transition of trade process to digital rails.
  • GOVERNMENT MODERNISATION OF THE 'OLD' PHARMACEUTICAL BUSINESS (2008—2011). REPORT 2. PHARMACEUTICAL FUTURE AND BIOSAFETY

    Ignatiev V.G., Zatravkin S.N.
    717-724
    Abstract
    This series of articles is devoted to an analysis of the drug safety policy of the Russian Federation. The second communication focuses on the history of strategy development and choice of tactics for pharmaceutical industry modernisation, the spectrum of interests of the concept-makers and the contradictions between the approaches. Based on journal publications and oral interviews, the authors traced the process of creating a regulatory agreement between political authorities and professional groups on power sharing and management delegation after the recognition of the pharmaceutical market as an object of state security
  • The Renaissance of Russian pharmaceutical market (2000-2004). Report II. The Pharma servants of Russia

    Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
    112-119
    2023-12-15
    Abstract
    The article (the third one of authors cycle of historical studies of medication supply and pharmaceutical business) examines period of economic renaissance of the Russian pharmaceutical market in the first years of third millennium. The state of market according data of Russian analytical agencies, medical periodicals and recollections of participants is considered. The article consists of three reports. In the first report the issue was the “field players” of pharmaceutical market, and in the second one - all the personnel serving market game, making it possible, their reflections on their new, post-Soviet experience of life in private business.
  • The Russian pharmaceutical branch in 1990s. Report 1. From the Soviet to the market

    Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
    160-166
    2022-12-15
    Abstract
    The article opens series of publications devoted to the history of occurrence of pharmaceutical market in Russia. The specifics of medication supply system in the Soviet period, circumstances of its deconstruction in early 1990s and modes of overcoming medication scarcity in 1993-1994 are considered. The authors compared publicly available digital data of 1990s documenting state of pharmaceutical branch, with testimonies of pharmaceutical market participants, their speculations on its state and conceptions about its normativity. This kind of methodological approach permitted to discover latent incentives and hidden obstacles in the history of Russian Pharma and to discern asymmetries of infrastructural development.
  • GOVERNMENT MODERNISATION OF THE 'OLD' PHARMACEUTICAL BUSINESS (2008—2011). REPORT 1. THREATS AND SECURITY

    Ignatiev V.G., Zatravkin S.N.
    711-716
    Abstract
    This series of articles analyses the drug safety policy of the Russian Federation. The first report reveals the reasons behind the government's dramatic turnaround in the pharmaceutical market and pharmaceutical industry, which emerged in 2007—2008. Based on publications, author interviews and unique protocol documents from the government archive, the logic and sequence of a new regulatory agreement between the pharmaceutical business and the Russian state are revealed.
  • The analysis and assessment of problems of medicinal support in The Russian Federation in actual conditions

    Telnova E.A.
    415-420
    2021-12-15
    Abstract
    The medication support of population is an integral part of health care system reflecting the state of social and economic sectors in conditions of national pharmaceutical market development that as opposed to markets of other goods has such specific characteristics as wide scale, large selection of assortment, science linkage, durational cycle of medication development.Lately, intensive work was implemented improving national medication supply system. The normative base passed through significant changes. The percentage of costs of medication support in total costs of health care increased. The preparation of pilot project concerning system of reimbursement of appropriated medications proceeds. However, despite all these actions, availability of medications does not improve. The components of medicinal availability can be structured as physical, spatial temporal, assortmental and infrastructural ones. The article presents overall analysis of most acute challenges in the area of medication supply. The proposals were formulated concerning development of system of medication support of population.
  • The 1998 default and the pharmaceutical market. Report 2: Predictions and Estimates

    Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
    903-908
    2022-12-15
    Abstract
    In a series of articles, researchers analyze the significance of the 1998 default for the development of the pharmaceutical industry and for the fates of pharmaceutical market participants. The second communication presents the results of an analysis of predictive statements and the collective memory of representatives of the pharmaceutical community. The analysis was carried out on the basis of the interviews published in pharmaceutical publications and taken by the authors of the article during 2019-2021. A total of 43 texts were used.
  • The long 1992 in medicinal (non-)security of Russia. Report II. Market networks and institutes

    Ignatiev V.G., Zatravkin S.N., Vishlenkova E.A.
    2025-04-22
    Abstract

    The year of 1992 is very important milestone in history of Russian pharmaceutical market. It began not in January 1922, but in December 1991, when the President and Government enactments to open free market for medications were promulgated. The advisers of B. N. Yeltsin considered market economy as reliable mean to overcome medicinal deficiencies, corruption and bureaucratic monopoly. However, panacea did not work. Moreover, it caused completely new problems. The human and state security implies protection from threats of dependencies. The unprepared dive into market plunged Russians and the country into severe dependence on import of medications and foreign pharmaceutical companies.
    The proposed study expands our publications in this journal and in journal “Pharmacy” in 2022. At that time, analysis of medication scarcity was implemented on the basis of published sources and relied on journalistic evidences. The current study is carried out on the basis of archival documents of the Ministry of Health Care of the Russian Federation and authors interviews of representatives of regulator. The second report reconstructs the sequence of the emergence and correlation of the structural elements of the Russian pharmaceutical market.

1 - 21 of 21 items

Make a Submission

Make a Submission

Browse

  • Categories
    • Health and Society
    • History of medicine
    • Education and personnel
    • Health care reforms
    • From Practice of Health Care Professional
    • Abroad
    • COVID-19
    • Reviews

Information

  • For Readers
  • For Authors
  • For Librarians

Latest publications

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Mailing address

Адрес: 105064, Москва, ул. Воронцово Поле, д. 12

Email: ttcheglova@gmail.com

Телефон: +7 903 671-67-12

Editorial office

Щеглова Татьяна Даниловна
FSSBI «N.A. Semashko National Research Institute of Public Health»

E-mail:

© 2026 Journal «Problems of Social Hygiene, Public Health and History of Medicine»